Idera Pharmaceuticals
Biotechnology, 15 Tw Alexander Dr Ste 418, Durham, North Carolina, 27709, United States, 11-50 Employees
Phone Number: 48********
Who is IDERA PHARMACEUTICALS
Idera Pharmaceuticals now Aceragen, a rare disease biopharmaceutical company. We address rare, orphan diseases that typically have no available treatment, and strive to develop novel ther...
Read More
-
Headquarters: 15 Tw Alexander Dr Ste 418, Durham, North Carolina, 27709, United States
-
Date Founded: 1989
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2834
|
NAICS Code: 446110 |
Show More
Does something look wrong? Fix it. | View contact records from IDERA PHARMACEUTICALS
Idera Pharmaceuticals Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Idera Pharmaceuticals
Answer: Idera Pharmaceuticals's headquarters are located at 15 Tw Alexander Dr Ste 418, Durham, North Carolina, 27709, United States
Answer: Idera Pharmaceuticals's phone number is 48********
Answer: Idera Pharmaceuticals's official website is https://aceragen.com
Answer: Idera Pharmaceuticals's revenue is $1 Million to $5 Million
Answer: Idera Pharmaceuticals's SIC: 2834
Answer: Idera Pharmaceuticals's NAICS: 446110
Answer: Idera Pharmaceuticals has 11-50 employees
Answer: Idera Pharmaceuticals is in Biotechnology
Answer: Idera Pharmaceuticals contact info: Phone number: 48******** Website: https://aceragen.com
Answer: Idera Pharmaceuticals now Aceragen, a rare disease biopharmaceutical company. We address rare, orphan diseases that typically have no available treatment, and strive to develop novel therapies which can have a positive impact on the lives of patients and families. As such, the needs of the patients who suffer from neglected rare diseases drive our mission first-and-foremost. Our goal is to provide rare-disease patients with compelling new therapeutic options that will allow them to lead the fullest lives possible. Such diseases have been frequently overlooked for drug development and remain orphan due to the assumption that they have a small individual footprint. We aim to change this outlook, engaging in community awareness, regulatory outreach, and most importantly, delivering novel treatments. By focusing on rare and orphan diseases, we hope to bring a much-needed spotlight to the area by leveraging our collective conviction that these efforts will change the world for the better.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month